NCT03803410View on ClinicalTrials.gov

Surveillance of HCV in Uremics and Linking to Medical Care

CompletedOBSERVATIONAL
Enrollment

2,973

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
Hepatitis C
Interventions
PROCEDURE

blood test, noninvasive test for liver fibrosis

blood test of HCV serology and virology.noninvasive test including M2BPGi and fibroscan for liver fibrosis

Trial Locations (1)

807

Kaohsiung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT03803410 - Surveillance of HCV in Uremics and Linking to Medical Care | Biotech Hunter | Biotech Hunter